US President Donald Trump will meet on Thursday with executives from major pharmacists, a White House official confirmed Reuters On Wednesday, as the industry is trying to gain government support for drug pricing and insurance changes.
The meeting is expected to cover issues, including Medicare drug bargaining, the role of pharmacy benefits and tariffs on medicinal products, according to a source in the industry with knowledge of the issue.
The White House did not say who will be present but Parachute It was reported on Tuesday that the meeting would include Stephen UBL, head of America’s pharmaceutical research and manufacturers, the main lobby group for pharmacists.
Pharmacists, who are fighting with a wild card from Trump from a potential 25% invoice in pharmaceutical imports, are exploring the possibility of exceptions granted by the government for drugs in import tasks.
US Republican President Mike Johnson said last week that he believed Trump was thinking of exceptions in mutual invoices involving automakers and pharmaceutical industries.
Drugmakers are hoping to change a Biden Act that allows Medicare, the government’s health plan for Americans aged 65 and over, to negotiate prices for its most expensive medicines, including Novo Nordisk’s popular Wegovy drug.
The industry is also pushing for curbs to discounts paid pharmacy benefits managers who act as intermediaries between pharmaceutical companies and consumers, in return for favorable placement in the insurance coverage lists. They argue that these discounts contribute to the high price of prescription drugs.
Trump previously met with UBL and executives of US Drugmakers Pfizer and Eli Lilly at the Mar-A-Lago estate in Florida in December, according to reports.
a href=”https://www.geo.tv/latest/591636-trump-to-meet-pharma-leaders-as-they-seek-drug-policy-changes”>Source link
